Company: BDRX
Filing Date: 2025-11-17
Form Type: POS AM
Source: 0001214659-25-016809
Chunk: 99

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: POS AM
Chunk 99
---
us does not contain
all of the information contained in the registration statement, you should read the registration statement and its exhibits and schedules
for further information with respect to us and our Ordinary Shares and the Depositary Shares.

We are subject to periodic reporting and
other informational requirements of the Exchange Act, as applicable to foreign private issuers. Accordingly, we are required to file reports,
including annual reports on Form 20-F, and other information with the SEC. As a foreign private issuer, we are exempt from the rules of
the Exchange Act prescribing the furnishing and content of proxy statements to shareholders under the federal proxy rules contained in
Sections 14(a), (b) and (c) of the Exchange Act, and our “insiders” are exempt from the reporting and short-swing profit recovery
provisions contained in Section 16 of the Exchange Act. The SEC maintains an Internet site that contains reports, proxy, information statements
and other information regarding issuers at http://www.sec.gov. You can review our SEC filings and the registration statement by accessing
this website. Copies of certain information filed by us with the SEC are also available on our website at http://www.biodexapharma.com.
Our website is not a part of this prospectus and is not incorporated by reference in this prospectus.

<div align='center'>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</div>

The SEC allows us to “incorporate
by reference” the information we file with the SEC, which means that we can disclose important information to you by referring you
to another document filed separately with the SEC. The information incorporated by reference is an important part of this prospectus.
We incorporate by reference, as of their respective dates of filing, the documents listed below that we have filed with the SEC and any
documents that we file with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus
and prior to the termination of the offering of securities under this prospectus (except in each case the information contained in such
documents to the extent “furnished” and not “filed”):

Any statement contained in any document
incorporated by reference herein shall be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement
contained in this prospectus modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except
as